Desiree Perez & Roc Nation

The revenue from the entertainment industry sector in 2016 was an estimated $17.2 billion with a third of the revenues worldwide. One of the industry’s top recognized people is Des Perez who is a part of Jay Z’s business interest’s expansion. Des Perez has been a part of optimizing profits for the Carter’s a company of corporate entities for talent development, music production and concert tour management. She is known for her toughness in negotiations and being able to maximize the development of the talent she is overseeing.

One of the deals Ms. Perez was involved in during 2008 was a $150 million dollar deal with Live Nation that was going to expire. An announcement was made for a renewal of a 10-year agreement that was good for Roc Nation founded in 2008 and the artists the company represented.

Miss Perez has a long history of working with SC Enterprises and has been a close associate of Jay Z for nearly 20 years. Desiree Perez is known in the industry as a tough negotiator who helped negotiate the Formation stadium deal for Beyonce and had a hand in the Samsun deal for Rihanna. She was also a producer for the LifeParticle Effect tour in 2013 and in 2014 On the Run Tour for Beyonce and Jay Z and read full article.

Desiree Perez is involved with SC Enterprizes, ROC Nation, and other Shawn Carter business interests. She is married to Juan Perez and with him; she is part of the Hova Circle of Influence, which is a collective of people of influence and investors in the entertainment and music industry. While the audience doesn’t see it behind successful performers is a professional making the business decisions that ensure the tour or concert will be a success. This lends more recognition to Des Perez since it is usually a male dominated profession in the music and entertainment industry and what Dez Perez knows.

More Visit: http://staithes.org/desiree-perez-is-leading-roc-nation-and-tidal-to-big-success/

Scott Rocklage and His Role with 5AM Ventures

**UPDATE AUGUST 6th**

Dr. Scott Rocklage’s High Level Of Intelligence Has Built An Incredible Career

Dr. Scott Rocklage has achieved many milestones in his career and inspired entrepreneurship and biochemical research. He began his work with 5AM Ventures in 2003 with almost thirty years of experience. His strategies in healthcare are a combination of his scientific experience, background and leadership capabilities. He additionally chairs the Boards for Achaogen, Relypsa, Cidara Therapeutics, Rennovia, Kinestral, and Semprus. He has served prestigious companies in the healthcare field as CEO and his leadership abilities are superb.

 

Dr. Scott Rocklage’s educational background is impressive. He has earned a Bachelor of Science degree in Chemistry and a Philosophy degree in Chemistry. He worked with Richard R. Schrock, the Nobel Prize Winner in 2005 and was responsible for three new drugs receiving approval from the FDA. Six new drugs are being clinically tested because of Dr. Scott Rocklage. He holds thirty United States Patents and has in excess of 100 publications. Through 5AM Ventures he has studied new aspects regarding life science in addition to working with entrepreneurs. He is working on ways to improve healthcare with medical and scientific advancements.

 

Dr. Scott Rocklage uses modern techniques to diagnose, treat, and prevent numerous medical conditions. He has been involved with research regarding treating cancer with the use of new advancements and due to his efforts certain genotypes have more than one treatment option. He has contributed to extending the lives of cancer patients. His success is partially attributed to his organizational skills, time management, and prioritization. He firmly believes a companies success is based on the process of selection. He is insistent that when an entrepreneur fails it is connected to the area of management.

 

Dr. Scott Rocklage has built a reputation for bravery because he shows no fear of measured risks. He does not believe success is about going to work for a Fortune 500 company but based on the decision to become an entrepreneur. He places the success of his current company on their focus to work hard at what they are most qualified for and taking advantage of their strengths in business. This is the strategy that has kept his company successful even in the toughest times instead of the common approach of taking an easier direction. He has thanked the book Good to Great for supplying him with the basis for his career in business and calls the book a timeless tome. He feels it helped him understand performance and business and gives all the credit to the Massachusetts Institute of Technology.

In 2003, Dr. Scott Rocklage joined the 5AM Ventures team and in 2004 he was promoted to Managing Partner. He has over 30 years experience in management in healthcare. His leadership abilities are phenomenal and that landed the FDA approval of three new drugs. They are Omniscan, Cubicin and Teslascan. Dr. Scott Rocklage has held several positions over the course of his career. He served on the board as Chairman and CEO of Cubist Pharmaceuticals, and held numerous positions within the companies of Catalvtica and Salutar. Dr. Scott Rocklage actively is on the board as Chairman of Cidara, Rennovia, Epirus, Pulmatrix, and Kinestral. Dr. Rocklage has created or co-created more than 30 United States patents and over a 100 peer related publications. His office is located in Boston, MA.

He was interviewed by Ideamensch and it offered insight about his background and how the ideas of his business came to be. 5AM Ventures is his business that is based on science and life. For Dr. Rocklage, a typical day varies. Some of his days are spent researching untouched areas of life science and other days are spent working on his management portfolio. And when he’s not doing that, he is attending board meetings.

The ideas that become reality come from the people he works with. Dr. Rocklage works with various scientists, business executives, and physicians to help bring their ideas to life in areas where medical needs have not be touched or treated. One project that has captivated his interest is cancer treatments using mutations in different ways. He wants to save lives or extend patients that has been touched with cancer.

Organization keeps Dr. Rocklage on track with managing his time with the busy schedule he keeps on a daily basis. He was asked what would he change if he could start over again. Dr. Rocklage’s reply was to put more focus on more people. Team selection is imperative when starting a new company and what Scott knows.

Dr. Rocklage has offered advice to entrepreneurs out there and that is to not be afraid of risk-taking. That when you can control your future, you advance further than you would if you worked with an already established company. Stay true to what you can do well and don’t stray from your strengths. The best advice he can give the community is to read this classic book called “Good To Great“. This will help those on the outside understand performance and business.

More visit: https://ideamensch.com/scott-rocklage/

Jason Halpern: A New York Success Story

Jason Halpern: Real Estate Entrepreneur
Jason Halpern: Real Estate Entrepreneur

When it comes to residential and commercial properties across the United States, real estate developers are faced with numerous challenges. Whether it’s deciding which properties to develop or how to coordinate with a construction team, various tasks can ultimately make some projects difficult for many developers to take on and complete. But when it comes to famed real estate developer Jason Halpern, accepting a new challenge is exactly what he craves.

 

When Jason took over his family’s extensive real estate business seven years ago, he quickly saw one opportunity after another. Currently having more than $500 billion invested in various projects across New York, JMH Development has concentrated on locating properties that others feel are worthless and instead turning them into luxury developments. This has been showcased time after time by Jason and his team, especially with the creation of 184 Kent. While others saw merely a broken-down warehouse, Jason instead saw a property filled with promise. By working closely with his team, construction experts, and local officials, JMH was able to turn 184 Kent into 340 luxury apartments, showing others what a unique vision for success can achieve.

Jason Halpern Real Estate Partner of Aloft Property
Jason Halpern Real Estate Partner of Aloft Property

However, Jason was not one to rest on his laurels. Along with 184 Kent, he has also been a key player in helping to revitalize one of New York’s most beloved and popular communities, Brooklyn. Again on the lookout for developing luxury homes for residents, JMH Development eventually built nine luxury townhouses known as the Townhouses of Cobble Hill. Defined as luxury at its finest, these properties illustrate the commitment Jason has to making New York a fabulous place to live.

Daniel de la Vega, Aviv Siso, Laura Garcia, Louis Buckworth, Thomas Juul Hansen and Jason Halpern
Daniel de la Vega, Aviv Siso, Laura Garcia, Louis Buckworth, Thomas Juul Hansen and Jason Halpern

Along with developing luxury living spaces, JMH Development also has an excellent reputation for helping to preserve historic places within various communities. Because of this, Jason has been looked upon within the industry as a developer with a sixth sense for success. Continuing on his quest to create even greater projects, Jason knows it will take a strong effort by he and his team. However, with his knowledge and experience, it’s clear Jason will beat the competition time after time.

The Industrious Career Path that Led Eric Lefkofsky to Help Improve Cancer Treatments

Eric Lefkofsky is the CEO and co-founder of a company called Tempus. This company was founded specifically for the purpose of creating more comprehensive databases for the treatment of cancer. While there is plenty of information available to assist in the treatment of cancer it is too wide spread to fully benefit the people who need it. Gathering clinical data is as important as gathering data related to the molecular structure of the illness. Making sure the clinicians working with patients have information about the current treatments they are on could significantly improve the overall statics related to recovery. This information could also be used to help facilities obtain the type of grants they need to operate effectively.

A Long and Productive Career

Eric Lefkofsky has always been an enterprising individual. After graduating from the University of Michigan, he and a friend started their own business selling apparel. Even while he was attending school, Mr. Lefkofsky still utilized his entrepreneurial skills by selling carpet. Although his most prominent company is Groupon, he has had a long string of productive ventures, which also led him to co-found Tempus. The rich history Eric Lefkofsky has in the world of business provided him with the insights needed to create many successful service-oriented businesses including one called Innerworkings, which provided print procurement services to medium-sized companies. Click here to know more.

Eric Lefkofsky’s dedication to providing businesses with needed services extends to his philanthropic ventures. He and his wife established the Lefkofsky Foundation, which is aimed at assisting charitable organizations in the fields of science and education. Currently this foundation has been able to assist more than 50 organizations. Mr. Lefkofsky also takes an active interest in his community by sitting on the boards of several high profile businesses including the Children’s Memorial Hospital and the Chicago Institute of Art. In alignment with his desire to provide better information to the general public Eric Lefkofsky has also written a book on the efficient use of technology in the business world. This was a natural followup to the courses of Applied Technology he taught at the DePaul University as well as at the Kellogg School of Management.

Facebook: Facebook.com/eplefkofsky/